Abstract:
Microneedle patch device has been widely utilized for transdermal drug delivery in pain management, but is challenged by accurate control of drug release and subsequent diffusion to human body. The recent emerging wearable electronics that could be integrated with microneedle devices offers a facile approach to address such a challenge. Here a 3D printed microheater integrated drug-encapsulated microneedle patch system for drug delivery is presented. The ink solution comprised of polydimethylsiloxane (PDMS) and multiwalled carbon nanotubes (MWCNTs) with mass concentration of up to 45% is prepared and used to print crack-free stretchable microheaters on substrates with a broad range of materials and geometric curves. The Treatment of low back pain through the systemic administration of medication is an essential approach in pain management, in particular for the pain that is usually associated with a variety of pathological conditions. Transdermal delivery of medication to local on-sites is considered superior to oral administration because of reduced side effects such as peptic ulcer and gastrointestinal bleeding and avoided liver first-pass metabolism. [1] Traditional technologies of drug delivery range from the early topical pain patches to recently developed microneedle patches. [2] Topical pain patches rely on the natural diffusion mechanism of drugs from the surface of the skin into the body, which is limited to the use of small molecular drugs with molecular weight less than 500 Da. [3] In contrast, microneedles that are usually in hundreds of micron length range creates microchannels by penetrating through the skin's natural defense barrier -stratum corneum (SC) with relatively little or no pain and allows a direct permeation of drugs into the body with enhanced delivery efficiency for a wide scope of drug size and categories, such as peptide, protein, antibodies and nanomaterials. [4] To ensure the skin permeability and achieve the accurate release of drugs that is of critical importance in defining the personalized treatment protocol, microneedles with a range of shapes and materials have been designed, for example, solid microneedles for pre-treatment skin, [5] coated microneedles with medication, [6] hollow microneedles filled with the drug solution, [7] and dissolvable microneedles made of controllable degradable rate of polymer materials. [8] Several physical methods have been developed in conjunction with microneedles to control the diffusion of drugs in the body for disease specific applications of relevance to pain, for example, ultrasound, [9] iontophoresis, [10] electroporation, [11] chemical enhancers. [12] Alternatively, heat that can be taken easily and inexpensively from the form of hot clothes, hot baths, and heating pads/wraps could be used to accelerate the diffusion of drug molecules as the increase of temperature could promote the movement of molecules, [13] thus helping control delivery of drugs. Besides, as a traditional straightforward way, heating has proved to help short-term pain relief such as acute low back pain due to increased blood flow, softened surrounding tissues, and associated metabolism and physiological effects, often referred as heat therapy or thermotherapy. [14] In practical applications, it emerges as an attractive approach in transdermal delivery of medication to integrate the heat therapy with microneedle patches to create a single simple smart sensor-assisted microneedle patch system that could control and monitor the release of drugs in an efficient manner. Recent development of technologies in 3D printing of functional structures and electronic devices could provide an opportunity to manufacture this smart system. [15] Here, we present a drug-encapsulated microneedle patch system integrated with a 3Dprinted microheater device and demonstrate that the control of drug delivery rate can be well controlled by regulating the temperature with the microheater. The printing ink solution consisting of multiwalled carbon nanotubes (MWCNTs) and polydimethylsiloxane (PDMS) is developed with the concentration of MWCNTs up to 45% (10 time higher than ever) [16] and the 3D printing ability of microheater on various material and geometric types of substrates are demonstrated. In particular, its adhesion with the surface of carboxymethyl cellulose enabled microneedles is evaluated as the heating function operates, and a facile strategy is proposed to enhance their integration adhesion by tuning the ink solution. In vitro tests on rat's skin is conducted to assess the functional abilities of the microheater integrated microneedle patch system in drug delivery. These studies provide a new route to design and manufacturing of sensor controlled medical devices and also establish the foundations for improving pain management via microneedle patches by seamlessly integrating wearable electronics to meet requirements for clinical use.
Materials, design and 3D printing of microheater:
We first investigate the droplet spreading of the MWCNTs/PDMS ink solution on a solid surface. Figure 1a shows the schematic illustration of an ink droplet with the contact diameter of printed on a curved substrate with the curvature of . Heights of the droplet before and after spreading are denoted as and , respectively. The system total energy of the droplet on the surface at equlibrium that includes both the solid-liquid interaction energy and gravitational potential energy of the droplet proves to be a functional of / . With the energy minimization and the conservation of droplet mass, / can be quantitatively determined and will depend on the radius of printing needle and substrate, and (See method for theoretical analysis, and Figure S1 in Supporting Information). Here we define the liquid spreading will not occur when / is larger than 90%, i.e. the final collapsed height is more than 90% of the initial height, and the printed devices on this curved substrate will achieve the pattern as designed. to curing agent were used to prepare the solution inks [17] , and the extrusion-based ink jet printing (Sterile standard blunt needle, 1.8mm, Cellink, Inc.) was used to generate an ink droplet. for the MWCNTs concentration of 10% and 3%, respectively, which corresponds to nonspreading and spreading of the droplet on the surface, similar to those observation in the flat substrate. Both measurements with these two different MWCNTs concentration in the ink solutions show good agreement with theoretical predictions. Besides, a higher / is obtained on a curved substrate, which is in good consistence with theory as well.
With the fundamental elucidation of ink droplets on the substrates, we will print the microheater with the same MWCNTs/PDMS ink solution (see method). Hexane was added to decrease the viscosity of ink solution and benefit the extrusion from nozzles, which is of critical importance for a high concentration of MWCNTs (>5%). [18] The extrusion rate of ink solution was 12 mm/s and the thickness of printed layer 800 μm. The printed devices were cured in 80°C for 2.0 hours. to the rise of applied power, suggesting the typical joule heating mechanism in the microheater.
Figure 3b
shows the measured temperature change under a cyclic loading condition of voltage.
The same of equilibrium temperature without obvious thermal degradation in each voltage cycle indicates the stability of heating performance of the printed devices for a long-term use. Figure   3c further presents the effect of the concentration of MWCNTs in ink solution on the electrical resistance and equilibrium temperature in printed microheaters. The electrical resistance shows a dramatic drop when the concentration of MWCNTs increases from 20% to 35% and decreases in a relatively slow manner beyond 35%, contributed by the formation of intense conductive networking in PDMS. As a consequence, the equilibrium temperature shows an increase at a higher concentration of MWCNTs. Figure 3d shows the variation of electrical conductance in the devices on PDMS substrate under a stretching loading. PDMS substrate is stretched with a homemade stretcher, as inset at the upper left corner. Approximately linear relationship between them is obtained, independent of the concentration of MWCNTs. The sudden increase of electrical conductance at ~30% stretching strain suggests the failure of microheater. This large stretchability could easily coordinate with large deformation (~20%) [19] of human skin accompanied with typical physical activities, potentially useful for pain relief by printing microheater on the skin.
When microheater is printed on the back surface of microneedle patch (Figure 2f ), we performed peel-off experiments to investigate their adhesion strength under an elevated temperature. Figure 4a shows the peeling force-displacement curves under a various equilibrium temperature generated by microheater. Typical three stages are observed, 0 ̶ 2 mm and 4 ̶ 6 mm for delamination between PDMS layer and cellulose microneedle patch substrate, and 2-4 mm for detachment of microheater from the cellulose microneedle patch substrate. In addition, a higher heating temperature leads to a lower peeling force. It is noteworthy that the slight increase of peeling force at peeling distance of 2-4 mm results from the meander pattern of microheater. Further, we performed the peel-off experiments on printed devices with different ratios of base polymer to curing agent of PDMS in the preparation of PDMS-MWCNTs ink solution. Figure 4b shows the effect of PDMS in ink solution on adhesion strength at the heating temperature of 44°C. A lower concentration of PDMS curing agent in ink solution leads to a higher peeling force, suggesting a subtle approach to prevent detachment of microheater from microneedle patch at elevated heating temperatures.
In vitro evaluations using rat skin: Evaluation of drug diffusion and release using freshly excised skin specimen provides a viable approach for validating physiochemical performance of microheater integrated microneedles. The microheater with the MWCNTs concentration of 20% in the ink solution was directly printed on the back surface of microneedle encapsulated with a model drug-the near-infrared fluorescence dye Cy5 (Figure 1f ). After the power is switched on, microheater starts to generate heat at desired temperature to facilitate microneedle drug delivery from three aspects: 1) Microheater accelerates the dissolving process of microneedles in the presence of skin fluid (when microneedles inserted into the skin) and thereby accelerating the release of encapsulated drug molecules. 2) Heat or mildly elevated skin temperature can facilitate drug diffusion from the stratum corneum/epidermis (the microneedle application site to deeper dermis tissues that are rich in nerves and blood vessels, due to increased thermal movement of drug molecules. Reaching the dermis tissue in a faster mode ensures the faster-acting therapeutic effect of drug. This "fast-acting" characteristic is particular important when treating pain symptoms. This is also the reason why "heated lidocaine pain patch" has been widely studied and utilized in the clinical setting to alleviate pain. 3) It is well known that local heat can increase blood circulation which further facilitate the drug diffusion and absorption to improve the treatment outcome. We did not observe any skin damage or irritation caused by the heating as showed in Figure S7 in the Supporting Information. The therapeutic performance of microneedles and other topical administration methods could be assessed by the amount of initial drug loading on-site as well as the diffusion of drug molecules in the blood circulation through the skin. We adopted an established in vitro drug release model to assess the diffusion property of our system using rat skin. Figure 6a demonstrates accelerated model drug Cy5 release from rat skin administered with the microheater assisted microneedle compared to microneedle only group. By comparing the quantitative fluorescence intensity of Cy5 diffused from post-application rat skin (with the same 1 ×1 cm 2 dimension encompassing the entire microneedle application areas), we observed that microheater facilitated more and faster drug release and diffusion (higher fluorescence intensity) along the time for up to 48 hr post incubation of skin specimen in PBS buffer (Figure   6b ). The slow release phase of the first 25 min followed by a much faster rate in Figure 6 can be interpreted as the traveling time of model Cy5 drug to reach the contact surface of skin and PBS aqueous buffer. This result is consistent with the observation in Figure 4c , indicating that our microheater integrated microneedle system not only increases the initial drug depot at local skin application site but also facilitates drug release and diffusion via accelerating microneedle dissolving, drug release and drug permeation depth in skin.
In summary, we reported a microheater integrated microneedle patch system for drug release and diffusion control that can address the critical needs in pain management with on-demand dose requirement. The preparation of high concentration MWCNTs/PDMS ink solution that can be directly utilized for 3D printing devices including microheater in substrates with a broad range of material and geometric features lays the foundation for the development of ink-based electronics devices with capability of sustaining large deformation and flexibility.
The integration performance with tunable interfacial adhesion strength by adjusting PDMS curing ratio in ink solution indicates a facile approach to achieve a robustness interface, even at elevated temperature conditions. In vitro evaluation experiments to track the release of drug from microneedle into rat's skin demonstrate the controlling ability of drug release by heating function via integrated microheater. These results pave a new route to develop electronic sensors integrated controllable smart drug delivery system with broad potential applications of drug molecules in disease treatments.
Experimental Section
Theoretical model and analysis of a 3D printed ink droplet on curved substrate: Consider the 3D printed liquid droplet riding on a curved substrate with a radius of curvature ( Figure S1a ), before the spreading occurs, the height of the droplet is = − (1) where = + , = ( / ), and = / ( ). is the intrinsic contact angle of the liquid droplet on the corresponding flat surface and is the contact radius. The total surface energy of the system is
where is the surface area of the liquid, − is the interface area between the substrate and liquid, and is the area of the substrate exposed to the air. . Therefore, the total energy of the system becomes
The conservation of liquid volume ( = ′ )leads to
Besides, assume the 3D printed liquid droplet is spherical, we will have
where is the radius of the ink droplet.
Based on Eqs. (9) and (10), we can solve ′ as a function of . When ′ reaches its minimum, the corresponding is the height of droplet after spreading. We here define if / ≥0.9, the change of height after spreading is very small and the droplet spreading can be neglected. Otherwise, if / <0.9, the droplet spreading will happen. Figure S1c shows the variation of the total energy after spreading normalized by the total energy before spreading ( ′ / ) with the height of the droplet after spreading over the height of droplet before spreading ( / ). When the total energy reaches the minimum, / can be determined as marked. The larger droplet (i.e. a large ) is, the smaller / will be, suggesting the easier spreading of droplet. Similar findings are also found at a lower concentration (i.e. lower surface tension of liquid) of MWCNTs in MWCNTs/PDMS ink solution ( Figure S1d ).
Preparing of ink solution and 3D printing of devices: PDMS pre-cursor (Sylgard 184 Silicone
Elastomer, Dow Corning Corp.) was firstly mixed with hexane solution (n-Hexane, anhydrous, 95%, Sigma-Aldrich) in a weight ratio of 10:4 in a 50 ml conical tube. Hexane was added to the mixture to ensure a moderate viscosity of mixture. Then, MWCNTs (8-15 nm diameter, 10-15 μm length, 95%, Nanostructured & Amorphous Materials, Inc.) was added to the mixture in a certain concentration (MWCNTs: PDMS in weight). After robust stirring with a stir bar, cartridge was delivered to an ultrasonicator for at least 12 hours with 40 kHz to achieve a homogeneous distribution of MWCNTs in PDMS-Hexane mixture. The mixture was then degassed with a vacuum chamber. Afterward, curing agent of PDMS was added to the mixture in a ratio of 10:1 by weight. The prepared ink solution was loaded to 3D printer (Cellink, Inc.)
for use. After several printing, the optimized size of printhead for this research was set to be 14G to decrease the risk of clogging meanwhile keeping the width of microheater within tolerance.
In the printing of devices, the inks were extruded with a printing speed of 12 mm·s -1 .
Printing layer height was 800 μm. After the desired pattern was printed, it was delivered to a controlled temperature chamber to be cured for 2 hr at 80°C. When the concentration of MWCNTs is as high as >25%, to avoid cracking, printed devices were first cured in temperature of 50°C for 10 min and then for room temperature of 25°C for another 10 min, which will help release of printing residual stress and air bubble in devices. This heating-cooling cycle, often referred to annealing process, was repeated for several times till the devices were completely cured.
Fabrication of microneedle patch: The fabrication of microneedle was conducted by following the protocol published in this paper. [20] In brief, ∼2 mg Cy5 (gift from Dr. Zhang lab at Cedars-Sinai, CA) was dissolved in 500 μL 8% (w/w) sodium carboxylmethyl cellulose (SCMC, Sigma-Aldrich, MO, USA) solution. Then 50 μL of this solution was added to a polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning, USA) mold containing cone cavities (44 cone cavities, each 1 mm in depth and ∼440 μm in base diameter; TheraJect, Inc., CA, USA), and centrifuged at 4000 rpm for 5 min to drive the solution into the cavities. The solution out of the cavities was removed after centrifugation and collected for reuse. After air-drying overnight, another 200 μL solution containing 8% (w/w) SCMC alone was poured on the mold and centrifuged at 4000 rpm for 1 min. The solution was dried overnight to form a microneedle patch. Then patch was peeled off from the mold with caution. After fabrication, microneedles patches were stored at 4 °C until use.
Biological evaluation using rat skin: Dorsal skin (12-14 wk, male) was obtained from cadaver Lewis rats. Skin hair was removed by hair clipper to provide a clean application area of ~3 cm×3 cm immediately after rats were euthanized in CO2 chamber. Microneedle with or without heater were then applied on rat skin for 10 min at either room temp (w/o microheater) or at 44°C (by microheater) in designated area on a foam box platform with four corners of skin extended by needle pinching. Optical images of skin before and after microneedle applications were taken to record the gross condition of skin surface and to confirm microneedle insertion.
After microneedle application, skin areas subjected to microneedle application were dissected in ~1 × 1cm 2 . The near-infrared fluorescence (NIRF) images of rat skin specimen after microneedle application were obtained to further confirm the successful microneedle insertion into the skin and to evaluate the amount of model drug deposited immediately after application.
Meanwhile, microneedles (both pre-and post-application) were attached in a 45° angel to glass slide with a clear tape and imaged with a Nikon DS-Ri2 digital microscope camera mounted on a Nikon Eclipse E-600 microscope with a DAPI (UV) channel to assess the gross structural change of microneedles with and without microheater assisted degradation. Skin samples immediately after microneedle application (with and without microheater) were divided into three groups: Group 1 for tissue fluorescence imaging; Group 2 for histology processing and hematoxylin/eosin staining; and Group 3 for in vitro diffusion assay in PBS buffer.
For fluorescence imaging of tissue slide: rat skins were snap frozen in liquid nitrogen and embedded in O.C.T. Compound (Tissue-Tek) immediately to avoid fluorescence signal loss. Cryostat was performed to obtain skin sections in 5-µm thickness and stored at -20°C until imaging. Fluorescence microscopy of rat skin tissue slide (without mounting) was performed using a Nikon DS-Ri2 digital microscope camera mounted on a Nikon Eclipse E-600 microscope with a TRITC channel. Images were captured with the exact same exposure time and analog gain at 200× magnification using the NIS Elements Software (Nikon Corp.)
following our published protocols. [21] For histological staining, rat skin specimen was fixed in 4% paraformaldehyde and embedded in paraffin block for sectioning at 5-µm thickness. Skin slides were then subjected to hematoxylin/eosin staining as previously. [22] Bright-field images at 200× magnification was taken to confirm successful insertion of microneedle with penetration of SC layers.
For in vitro diffusion assay, rat skin specimen after microneedle application (with and without microheater) were transferred into separate wells of 12-well plate containing 2 mL PBS buffer in each well to allow free floating of skin specimen. and more initial drug depot in skin (lower row) in microheater integrated group compared to microneedle only group. Scale bar is 500 μm for (a), 5 mm for (b) , 100 μm for first two in (c) and 5 mm for last two for (c). 
